MANNKIND CORP Increase (Decrease) in Accounts Receivable
MANNKIND CORP (MNKD) reported Increase (Decrease) in Accounts Receivable of $4.78 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-05
- MANNKIND CORP increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $15.07M.
- MANNKIND CORP increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$10.29M, a 160.19% decline year-over-year.
- MANNKIND CORP increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$817.00K.
- MANNKIND CORP increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$9.76M.
- MANNKIND CORP increase (decrease) in accounts receivable for fiscal 2025 was $4.76M.
- MANNKIND CORP increase (decrease) in accounts receivable for fiscal 2024 was -$2.65M.
- MANNKIND CORP increase (decrease) in accounts receivable for fiscal 2023 was -$2.35M, a 119.86% decline from fiscal 2022.
- MANNKIND CORP increase (decrease) in accounts receivable for fiscal 2022 was $11.81M, a 1421.52% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $15.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $4.78M 10-Q · filed 2026-08-05 | $3.96M derived: sum of 3 quarters · filed 2026-08-05 | -$5.80M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$10.29M 10-Q · filed 2026-05-06 | -$11.11M derived: sum of 2 quarters · filed 2026-05-06 | -$20.87M derived: sum of 3 quarters · filed 2026-05-06 | -$22.62M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$817.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$10.58M derived: sum of 2 quarters · filed 2026-02-26 | -$12.33M derived: sum of 3 quarters · filed 2026-08-05 | $4.76M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$9.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$11.52M derived: sum of 2 quarters · filed 2026-08-05 | $5.58M 10-Q · filed 2025-11-05 | -$801.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$1.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $15.34M 10-Q · filed 2026-08-05 | $8.96M derived: sum of 3 quarters · filed 2026-08-05 | $3.80M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $17.10M 10-Q · filed 2026-05-06 | $10.72M derived: sum of 2 quarters · filed 2026-05-06 | $5.55M derived: sum of 3 quarters · filed 2026-05-06 | $8.99M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$6.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$11.54M derived: sum of 2 quarters · filed 2026-02-26 | -$8.11M derived: sum of 3 quarters · filed 2026-02-26 | -$2.65M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$5.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.73M derived: sum of 2 quarters · filed 2025-11-05 | $3.73M 10-Q · filed 2025-11-05 | -$3.64M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $3.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $8.89M 10-Q · filed 2025-08-06 | $1.52M derived: sum of 3 quarters · filed 2026-02-26 | -$4.44M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $5.46M 10-Q · filed 2025-05-08 | -$1.91M derived: sum of 2 quarters · filed 2026-02-26 | -$7.88M derived: sum of 3 quarters · filed 2026-02-26 | $198.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$7.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$13.33M derived: sum of 2 quarters · filed 2026-02-26 | -$5.26M derived: sum of 3 quarters · filed 2026-02-26 | -$2.35M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$5.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.11M derived: sum of 2 quarters · filed 2024-11-07 | $5.02M 10-Q · filed 2024-11-07 | -$1.67M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $8.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $10.99M 10-Q · filed 2024-08-07 | $4.30M derived: sum of 3 quarters · filed 2025-02-26 | $12.76M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $2.91M 10-Q · filed 2024-05-08 | -$3.78M derived: sum of 2 quarters · filed 2025-02-26 | $4.68M derived: sum of 3 quarters · filed 2025-02-26 | $9.89M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | -$6.69M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $1.77M derived: sum of 2 quarters · filed 2025-02-26 | $6.98M derived: sum of 3 quarters · filed 2025-02-26 | $11.81M 10-K · filed 2025-02-26 |
| 2022-09-30 | $8.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $13.67M derived: sum of 2 quarters · filed 2023-11-07 | $18.50M 10-Q · filed 2023-11-07 | $14.05M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $5.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $10.04M 10-Q · filed 2023-08-07 | $5.58M derived: sum of 3 quarters · filed 2024-02-27 | $8.72M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $4.83M 10-Q · filed 2023-05-09 | $378.00K derived: sum of 2 quarters · filed 2024-02-27 | $3.52M derived: sum of 3 quarters · filed 2024-02-27 | $6.25M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$4.45M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$1.31M derived: sum of 2 quarters · filed 2024-02-27 | $1.42M derived: sum of 3 quarters · filed 2024-02-27 | $776.00K 10-K · filed 2024-02-27 |
| 2021-09-30 | $3.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $5.87M derived: sum of 2 quarters · filed 2022-11-08 | $5.23M 10-Q · filed 2022-11-08 | $5.31M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $2.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $2.09M 10-Q · filed 2022-08-09 | $2.17M derived: sum of 3 quarters · filed 2023-02-23 | $2.94M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | -$645.00K 10-Q · filed 2022-05-05 | -$562.00K derived: sum of 2 quarters · filed 2023-02-23 | $207.00K derived: sum of 3 quarters · filed 2023-02-23 | -$1.60M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $852.00K derived: sum of 2 quarters · filed 2023-02-23 | -$956.00K derived: sum of 3 quarters · filed 2023-02-23 | $705.00K 10-K · filed 2023-02-23 |
| 2020-09-30 | $769.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$1.04M derived: sum of 2 quarters · filed 2021-11-09 | $622.00K 10-Q · filed 2021-11-09 | $42.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$147.00K 10-Q · filed 2021-08-11 | -$727.00K derived: sum of 3 quarters · filed 2021-08-11 | -$1.61M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $1.66M 10-Q · filed 2021-05-12 | $1.08M derived: sum of 2 quarters · filed 2021-05-12 | $200.00K derived: sum of 3 quarters · filed 2021-05-12 | $1.42M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | -$580.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$1.46M derived: sum of 2 quarters · filed 2021-02-25 | -$246.00K derived: sum of 3 quarters · filed 2021-02-25 | -$504.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | -$881.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $334.00K derived: sum of 2 quarters · filed 2020-11-04 | $76.00K 10-Q · filed 2020-11-04 | $1.34M derived: sum of 4 quarters · filed 2020-11-04 |
| 2019-06-30 | $1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $957.00K 10-Q · filed 2020-08-05 | $2.22M derived: sum of 3 quarters · filed 2020-08-05 | $2.13M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | -$258.00K 10-Q · filed 2020-05-06 | $1.01M derived: sum of 2 quarters · filed 2020-05-06 | $911.00K derived: sum of 3 quarters · filed 2020-05-06 | $2.21M derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $1.17M derived: sum of 2 quarters · filed 2020-02-25 | $2.47M derived: sum of 3 quarters · filed 2020-02-25 | $1.34M 10-K · filed 2020-02-25 |
| 2018-09-30 | -$96.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $1.20M derived: sum of 2 quarters · filed 2019-11-08 | $74.00K 10-Q · filed 2019-11-08 | $1.06M derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $170.00K 10-Q · filed 2019-08-07 | $1.16M derived: sum of 3 quarters · filed 2019-08-07 | $1.65M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | -$1.13M 10-Q · filed 2019-05-07 | -$143.00K derived: sum of 2 quarters · filed 2019-05-07 | $349.00K derived: sum of 3 quarters · filed 2019-05-07 | $1.22M derived: sum of 4 quarters · filed 2019-05-07 |
| 2017-12-31 | $985.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $1.48M derived: sum of 2 quarters · filed 2019-02-26 | $2.35M derived: sum of 3 quarters · filed 2019-02-26 | $2.49M 10-K · filed 2019-02-26 |
| 2017-09-30 | $492.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $1.37M derived: sum of 2 quarters · filed 2018-11-01 | $1.50M 10-Q · filed 2018-11-01 | -$1.31M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $874.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $1.01M 10-Q · filed 2018-08-02 | -$1.80M derived: sum of 3 quarters · filed 2019-02-26 | $1.33M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $136.00K 10-Q · filed 2018-05-09 | -$2.68M derived: sum of 2 quarters · filed 2019-02-26 | $461.00K derived: sum of 3 quarters · filed 2019-02-26 | $317.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | -$2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $325.00K derived: sum of 2 quarters · filed 2019-02-26 | $181.00K derived: sum of 3 quarters · filed 2019-02-26 | $302.00K 10-K · filed 2019-02-26 |
| 2016-09-30 | $3.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $2.99M derived: sum of 2 quarters · filed 2017-11-07 | $3.11M 10-Q · filed 2017-11-07 | |
| 2016-06-30 | -$144.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$23.00K 10-Q · filed 2017-08-07 | ||
| 2016-03-31 | $121.00K 10-Q · filed 2017-05-10 | |||
| 2015-09-30 | -$48.76M 10-Q · filed 2016-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |